All Infection Prevention & Control articles – Page 3
-
NewsDisarming cause in lupus patients’ infections
Microbiology researchers from the University of Tennessee, Knoxville, have discovered why patients with the autoimmune disease lupus are susceptible to serious bacterial infections. Source: University of Tennessee University of Tennessee Assistant Professor Andrew Monteith and Eden TenBarge, a research technician in Monteith’s Lab. A new study ...
-
NewsNew therapy eliminates gum disease bacterium while preserving beneficial oral microbes
Researchers have created an innovative treatment for periodontitis that targets and eliminates harmful bacteria while preserving beneficial oral microbes essential for health.
-
NewsGenomic upheaval: How grapevine downy mildew builds its weaponry through structural chaos
Researchers have assembled two complete, chromosome-level genomes of Plasmopara viticola from distinct grapevine hosts, revealing that nearly 90% of the pathogen’s effector genes exist as locally duplicated gene clusters.
-
NewsNew Mexico measles outbreak estimated to cost $5.4 million
A cost analysis of the 2025 measles outbreak in New Mexico found that the outbreak carried an estimated societal cost of $5.4 million, or more than $53,000 per case.
-
NewsResearch funding to improve treatment for invasive fungal infections
The Federal Joint Committee is funding a new Germany-wide research project aimed at improving care for patients with invasive fungal infections.
-
NewsThinking beyond antibiotics in the treatment of urinary tract infections
A promising new study combines phage therapy (PT) with fecal microbiota transplantation (FMT) to treat recurrent urinary tract infections.
-
NewsResearchers investigate case of soft-tick borne relapsing fever in Austin area
Researchers report a likely case of soft tick-borne relapsing fever (STRF) in an Austin-area resident.
-
NewsEarly surgery for bacterial eye infection offers hope to patients
A new clinical trial shows that early vitrectomy surgery for acute endophthalmitis could be more beneficial to patients’ vision compared with the current antibiotic-first approach.
-
NewsScientists fight drug-resistant parasites with nature-inspired drugs
As parasites become increasingly resistant to existing drugs, researchers are working to develop a new generation of treatments for two serious infectious diseases: malaria and babesiosis.
-
NewsShort-chain fatty acids and bile acids signaling in chronic hepatitis B
Current therapies suppress chronic hepatitis but rarely achieve functional cure (sustained HBsAg loss). Emerging gut‑liver axis evidence shows that microbial metabolites modulate HBV replication and immunity.
-
NewsBioactive metabolite boosts HIV treatment response, reverses gut dysfunction
Scientists have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy in the nonhuman primate model of HIV/AIDS.
-
NewsTwo deadly flowers have big medical potential
Two plants that cause neurotoxicity and paralysis in the tiniest doses are also known to counter pain, malaria, cancer and pests. For the first time, researchers have discovered a way to recreate these powerful compounds in the lab - with the help of yeast.
-
NewsThe amino acid arginine helps the body fight tumors and viral infections
Scientists have discovered that an arginine-deficient diet impacts the immune system by stalling the production of the MHC-1 protein, which alerts the immune system to dangers such as a mutating cell or an invading virus.
-
NewsScientists bring Florida high school students to the front lines of pandemic preparedness
Thirty outstanding high school students from 18 communities across Florida arrived in Tampa last week for the Global Virus Network (GVN) Global Guardians for Pandemic Preparedness Program, curious about viruses and considering careers in science.
-
NewsTuberculosis drug discovery gets smarter with AI
Scientists have built an artificial intelligence tool to help scientists focus their efforts after initial screening of potential tuberculosis drugs. The team is also using AI to organize years of collaborative data into a searchable form.
-
NewsHighly reliable LFIA based on selenium nanoparticle reveals long-term real-world dynamics of neutralizing antibodies against SARS-CoV-2
SDS modified selenium nanoparticles enable reliable lateral flow immunoassay, showing that neurological and hematological patients lose vaccine induced immunity much faster.
-
NewsLeishmania: When tropical parasites use immune cells as a taxi
Tom Beneke intends to clarify, as part of the new Emmy Noether Research Group ‘LeishMove’, exactly how the Leishmania parasites control their host cells and which variations in the parasites are necessary for this.
-
NewsHepatitis B virus infection or reactivation and HBV-related liver dysfunction in patients with inflammatory bowel disease receiving infliximab
A real-world study examines HBV infection and reactivation rates in a large cohort of Chinese IBD patients treated with infliximab.
-
NewsResearch study investigates how maternal viral infections shape lifelong immune health in offspring
A $2.4 million grant will support research that aims to uncover how viral infections during pregnancy reprogram the developing immune system of the fetus, influencing susceptibility to infectious diseases throughout life.
-
NewsThe hepatitis E virus cannot infect mice - and here’s why
It has long been known that the hepatitis E virus cannot establish an infection in mice, but the reasons were unknown. Scientists have therefore systematically examined the replication cycle of the virus in liver cell cultures of mice.